トリビュー

株式会社トリビュー (TRIBEAU, Inc.) operates トリビュー (TRIBEAU), a Japanese review and booking app for aesthetic medicine covering cosmetic surgery (美容外科), cosmetic dermatology (美容皮膚科) and cosmetic dentistry (審美歯科). Within a single app users can search reviews, treatments, clinics and doctors, and make online consultations or bookings. The service indexes clinics by region across Japan (Kanto, Kansai, Chubu, Kyushu/Okinawa, Hokkaido/Tohoku, Chugoku/Shikoku) as well as Korea, and by body area, concern, treatment category and budget; listed treatment categories range from double-eyelid procedures, rhinoplasty, liposuction and breast augmentation to lasers, injectables, medical hair removal and dental whitening.

The company was established on 26 July 2017 and launched the app in October 2017. It is headquartered at Toho Building 3F, 1-19-23 Ebisu, Shibuya-ku, Tokyo, and is led by representative director Dei Mou (毛迪), who founded the company after working in advertising sales at Recruit's Zexy and at a venture capital firm, motivated by the information asymmetry in aesthetic medicine. Capital stands at ¥600 million including capital reserves. Alongside the core app, the company publishes editorial columns and doctor interviews, has released features such as "クリニック選びアシスト" (patent applied for), the "ドクター質問箱" question box, "ドクター特集" doctor features, an AI consultation function, and a broader care service called "トリビューオンライン".

Founding story

Founder and representative director Dei Mou (毛迪) worked in advertising sales for Recruit's Zexy and then supported portfolio companies at a venture capital firm before founding TRIBEAU in the aesthetic medicine field, an area where he had personal experience and where information asymmetry is large; in the early phase he worked on the product himself.

Business model

TRIBEAU operates a two-sided marketplace: consumers use the app free of charge to research reviews and book treatments, while aesthetic clinics pay to be listed and receive bookings; the company solicits clinic listings through a dedicated inquiry channel and reports cumulative GMV from bookings made through the platform. It also offers a subscription contract option to users, and runs point-based incentives including treatment-cost point rebates, review-posting campaigns and friend-referral campaigns.

Revenue is tied to clinic listings and bookings transacted through the platform, measured by cumulative GMV, which reached ¥20 billion by October 2024 with sales growth reported at 175% year on year. User-side monetisation includes subscription contracts.

Traction

As of October 2024 the app had surpassed 1.5 million cumulative downloads and ¥20 billion in cumulative GMV, with revenue growing at about 175% year on year. Earlier, at the February 2022 Series B announcement, the company reported 650,000 cumulative downloads, 550,000 user-submitted photos, 1,400 clinics with reviews (out of roughly 3,000 domestic clinics), 556 bookable clinics, and 20,000 treatments booked through the platform (about 3x the prior year). The company cites a user satisfaction rate of 98% from a July 2024 web survey of 51 past users aged 15-49 conducted via GMO Research & AI.

Latest developments

Recent announcements include the formal launch of a patent-pending "クリニック選びアシスト" clinic-selection assist feature (February 2026), a "ドクター質問箱" question-box feature (April 2026), the トリビューオンライン total beauty care service (April 2026), a survey of aesthetic medicine trends among brides-to-be (May 2026), a "ドクター特集" doctor feature highlighting doctors' strengths (June 2026), a TBS television appearance by CEO Dei Mou (July 2026), and full provision of an AI consultation function for aesthetic medicine (August 2026). Funds from the January 2025 Series C second close are directed at business investment and hiring, including roughly 70 planned hires by end-2025 across product/engineering, marketing, business planning and sales, including CxO positions, plus generative-AI features and data integration with clinic systems such as electronic medical records.